Barclays PLC Reiterates Hold Rating for Mylan Inc.
's stock had its "hold" rating reaffirmed by Barclays PLC in a note issued to investors on Thursday. They currently have a $44.00 price objective on the stock.
from Biotech News
's stock had its "hold" rating reaffirmed by Barclays PLC in a note issued to investors on Thursday. They currently have a $44.00 price objective on the stock.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments